(Reuters) – Moderna Inc will be able to produce 500 million doses of its COVID-19 vaccine in 2021, Chief Executive Officer Stphane Bancel said on Friday
“For 500 million, I am very comfortable we are gonna get there (2021),” Bancel said, while speaking at the Nasdaq Investor Conference.
The CEO said the company will be able to maintain a premium price of $37 for its vaccine doses.
“For big volume supplies like to the U.S. government we can maintain $25 for doses”
(Reporting by Mrinalika Roy and Trisha Roy in Bengaluru; Editing by Anil D’Silva)
